Team and Sector Advisers

Stefan Constantin – Partner

Stefan Constantin is partner at C▪H▪Reynolds▪Corporate Finance AG. His primary focus is on Consumer Goods & Retail, Industrial Products, e-commerce, and the Healthcare/Pharma & Chemical sector.

After graduating in Business Administration in Frankfurt in 1992, he was employed at the corporate finance house Doertenbach & Co. There he advised on cross-border SME transactions, buy-side mandates for foreign companies and auctions with the participation of financial investors. In 1998, he founded C▪H▪Reynolds▪Corporate Finance AG together with Felix Hoch. Over the past 20 years, he has advised on numerous transactions of mid-sized companies and renowned financial investors, when selling their shares or portfolio companies, and has overseen a high number of international acquisition projects for publicly-listed multinational companies.

Stefan Constantin is a member of Vereinigung für Chemie und Wirtschaft VCW (Association for Chemicals and Business) and of Gesellschaft Deutscher Chemiker GDCh (Society of German Chemists). Moreover, he is member of the Business Advisory Board of FIZ – Frankfurt Biotechnology Innovation Center (Frankfurt Science City Riedberg), and the Frankfurt Society for Trade, Industry and Science.

He was Chairman of the Vereinigung deutscher M&A-Berater (VMA) until March 2014.

Contact: Telephone: +49 (0) 69 97 40 300; Email: s.constantin@chrcf.com

Dr Andreas J. G. Rauh – Sector Adviser Life Science, Pharma & Chemicals

Dr Andreas J. G. Rauh joined the Sector Advisory Board of C▪H▪Reynolds Corporate Finance AG in 2013. With longstanding international experience in the pharma and chemistry industry, he assists the C▪H▪Reynolds team in healthcare, pharmaceuticals and chemicals sectors.

Dr Rauh studied Chemical Technology at the University of Applied Sciences Darmstadt and Chemistry at the Philipps University Marburg. He also obtained several post graduate diploma from Kellogg’s/Northwestern University, USA, and Business School St. Gallen, Switzerland.

After his Ph.D. thesis in Molecular Immunology at the Max Planck Institute for Molecular Genetics in Berlin, Dr Rauh started his professional career at B. Braun Melsungen AG in 1988. He held various management positions in the Medtech and Pharma division and was responsible, amongst others, for the integration of acquired companies.

After switching to Merck KGaA in 1998, Dr Rauh held several leading and senior management positions and was responsible for the re-organisation of the Merck Chemicals Lab Business R&D departments and the implementation of portfolio- and project management. In addition to this, Dr Rauh was a member of the senior executive team for the integration of Millipore in the Merck organisation.

In his last position, Dr Rauh served as Senior Vice President and Head of Lab Essentials Merck Millipore and was General Manager at Merck Bioscience GmbH and Schuchardt oHG.

Since July 2013 Dr. Rauh founded the Panthaleon Strategy Management GmbH where he is acting as the general manager.